Nevro Corp (NYSE:NVRO)

83.00
Delayed Data
As of 6:30pm ET
 +2.16 / +2.67%
Today’s Change
34.75
Today|||52-Week Range
83.57
+113.42%
Year-to-Date
Here's Why You Should Retain Nevro (NVRO) in Your Portfolio
Aug 19 / Zacks.com - Paid Partner Content
Nevro Corp (NVRO) Q2 2019 Earnings Call Transcript
Aug 10 / MotleyFool.com - Paid Partner Content
Nevro (NVRO) Catches Eye: Stock Jumps 6.3%
Aug 13 / Zacks.com - Paid Partner Content
Nevro (NVRO) Q2 Loss Wider Than Expected, Revenues Down Y/Y
Aug 09 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close80.84
Today’s open80.78
Day’s range80.44 - 83.02
Volume345,973
Average volume (3 months)468,363
Market cap$2.5B
Data as of 6:30pm ET, 08/20/2019

Growth & Valuation

Earnings growth (last year)-30.98%
Earnings growth (this year)-137.77%
Earnings growth (next 5 years)+13.00%
Revenue growth (last year)+18.56%
P/E ratioNM
Price/Sales3.02
Price/Book9.98

Competitors

 Today’s
change
Today’s
% change
IRTCIrhythm Technologies...+0.53+0.71%
TNDMTandem Diabetes Care...+2.13+3.60%
BEATBioTelemetry Inc-0.41-0.99%
NTUSNatus Medical Inc-0.71-2.29%
Data as of 4:00pm ET, 08/20/2019

Financials

Next reporting dateNovember 11, 2019
EPS forecast (this quarter)-$0.83
Annual revenue (last year)$387.3M
Annual profit (last year)-$49.2M
Net profit margin-12.70%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
D. Keith Grossman
Vice President-
Operations
Patrick Schmitz
Corporate headquarters
Redwood City, California

Forecasts